DMD and cardiomyopathy: Moreover, it is possible to use iPSC-CMs from patients with different hereditary cardiac diseases, e.g., cardiomyopathy associated with mutations in the dystrophin gene, or to study different responses elicited by specific drugs versus iPSC-CMs from healthy subjects or genome-edited isogenic controls.